| Company |
Product |
Pathology |
Modality |
Features |
|
|
|
|
|
|
|
| Identification of |
| suspected findings |
| per pathology. |
| Core segmentation |
| and volume for |
| (M1 L)VO from |
| CTP. |
|
DL |
| FDA (II), CE (I) |
| (BriefCase ICI |
| triage) |
| (BriefCase LVO |
| triage) |
| (Briefcase BA |
| triage) |
| (icobrain-cva) |
|
| annalise.ai |
|
| ICH, ISL, |
| BA, |
| atrophy, |
| PVS, |
| SVD, |
| … |
| (130 total) |
|
NCCT |
| Detection or seg- |
| mentation of 130 |
| radiological |
| findings including |
| ICH subtypes, |
| infarcts, PVS, and |
| SVD. |
|
DL |
FDA (II), CE (IIb) |
| Avicenna.AI |
Cina |
|
|
| Identification of |
| suspected ICH or |
| LVO. ASPECTS |
| with infarct outline |
| and probability map |
| of hypoattenuation |
| and sulcal efface- |
| ment. |
|
DL |
| FDA (II), CE (I) |
| (CINA-ICH) |
| (CINA-LVO) |
| CE (I) |
| (CINA- |
| ASPECTS) |
|
| BRAINOMIX |
e-Stroke |
|
|
| ASPECTS with |
| infarct volume |
| and hypoattenuation |
| heat map (hyper- |
| attenuation also |
| detected indicating |
| bleeding). |
| Bounding box |
| on CTA for vessel |
| occlusion. Core |
| and penumbra |
| segmentation and |
| volume and mis- |
| match ratio from |
| CTP. |
|
|
| FDA (II), CE (IIa) |
| (e-CTA) |
| CE (IIa) |
| (e-CTP) |
| (e-ASPECTS) |
|
| BRAINSCAN.AI |
|
|
NCCT |
| Segmentation and |
| probability map of |
| ICH subtypes and |
| acute and chronic |
| ISL as well as areas |
| of atrophy. |
|
AI |
CE (IIa) |
| Cercare Medical |
|
ICH, LVO |
|
| Detects ICH. |
| Identifies |
| and provides |
| volume of |
| infarcted lesions. |
| Identifies exact |
| location of LVO. |
| Perfusion maps |
| from CT or MRI |
| perfusion |
| imaging and |
| additional |
| biomarkers of |
| oxygenation. |
|
DL |
CE (IIa) |
| CEREBRIU |
|
ICH, ISL |
|
|
AI |
CE (I) |
| Combinostics |
cMRI |
|
|
| Segmentation of |
| brain and atrophy |
| per region and |
| WMH per region; |
| longitudinal analysis |
| available. Outputs |
| structured report. |
|
RB |
FDA (II), CE (IIa) |
| cortechs.ai |
|
|
|
| Brain atrophy per |
| region from T1. |
| Segmentation and |
| volume of WMH |
| and longitudinal |
| analysis from |
| FLAIR. |
|
|
FDA (II), CE (IIa) |
| DEEP01 |
DeepCT |
ICH, LVO |
|
| Detection of ICH |
| (region, subtype, |
| volume, modified |
| Fisher scale, |
| Marshall score, |
| IMPACT score, |
| midline shift, and |
| Evans index). |
| Detection and |
| localisation of |
| LVO. |
|
DL |
FDA (II), CE (I) |
| icometrix |
icobrain |
|
|
| Segmentation of |
| ischaemic core and |
| penumbra from |
| CTP. Segmen- |
| tation and volume |
| and longitudinal |
| analysis of FLAIR |
| hyperintensities and |
| T1 hypointensities. |
| Brain volume |
| change metrics by |
| region from T1. |
|
AI |
FDA (II), CE (I) |
| INMED AI |
NeuroShield |
|
|
| Brain atrophy by |
| region, WMH and |
| CMBs (no info), |
| detection and seg- |
| mentation of ICH |
| and triage. |
|
DL |
|
| JLK |
|
ICH, ISL |
| NCCT, |
| CTP, T1, |
| T2, |
| FLAIR, |
| GRE, |
| PWI, |
| DWI |
|
| ICH localisation |
| and subtype (EDH, |
| SDH, SAH, IVH, |
| intracerebral) from |
| NCCT. Ischaemic |
| stroke subtype |
| probability |
| from DWI and |
| optional FLAIR, T1, |
| T2. Severity |
| probability |
| according |
| to the NIH stroke |
| scale from DWI. |
| Volume mismatch |
| from DWI/PWI. |
| On-set time |
| prediction and |
| ischaemic core seg- |
| mentation from |
| DWI/FLAIR. |
| Collateral map |
| analysis, ischaemic |
| core and penumbra |
| volume and mis- |
| match from CTP. |
| Infarct segmentation |
| and prognosis from |
| DWI and early |
| detection from |
| NCCT. |
|
|
| CE (I) |
| (JBS-01K) |
| (JBS-04K) |
|
| mediaire |
mdbrain |
|
|
| Brain volume by |
| region and long- |
| itudinal changes |
| from T1. Segmen- |
| tation of WMH |
| and regional |
| assessment and |
| longitudinal |
| changes from T1 |
| /FLAIR. Segmen- |
| tation of BA from |
| TOF. |
|
DL |
CE (I) |
| Methinks |
|
ICH, LVO |
|
| Notification of ICH |
| and LVO for |
| patient triage. |
|
DL |
CE (I) |
| neurophet |
AQUA |
|
|
| Brain atrophy by |
| region and longit- |
| udinal analysis |
| from T1. |
| WMH burden score |
| from FLAIR. |
|
DL |
CE (IIa) |
| NICOLAB |
|
|
|
| Segmentation and |
| volume of ICH |
| and SAH from |
| NCCT. ASPECTS |
| scoring. Identific- |
| ation and bounding |
| box of LVO and |
| collateral score |
| from CTA. Core |
| and mismatch |
| volumes from CTP. |
|
|
FDA (II), CE (I) |
| PIXYL |
Pixyl.Neuro |
|
|
| Segmentation and |
| volume of WMH |
| by region |
| and longitudinally |
| and brain atrophy |
| by region and |
| longitudinally. |
|
AI |
FDA (II), CE (IIa) |
| Quantib |
|
|
MRI |
| Brain atrophy by |
| region and longit- |
| udinal changes. |
| Segmentation of |
| WMH and longit- |
| udinal changes. |
|
ML |
FDA (II), CE (IIa) |
| QUBIOtech |
|
|
|
| Brain atrophy |
| quantification by |
| region and longit- |
| udinal changes |
| from T1. Segmen- |
| tation of WMH by |
| region and longit- |
| udinal changes |
| from FLAIR. |
|
|
CE (I) |
| qure.ai |
qER |
ICH, ISL |
NCCT |
| Bounding box and |
| volume for ICH |
| subtypes (IPH, IVH, |
| SDH, SAH, EDH). |
| Detects and quanti- |
| fies midline shift. |
| ASPECTS score |
| and outlines hypo- |
| attenuated area. |
| Bounding box for |
| acute and chronic |
| infarcts (including |
| lacunar). |
|
DL |
FDA (II), CE (IIa) |
| RapidAI |
|
|
|
| Identification of |
| ICH and segment- |
| ation and volume |
| of hyperattenuated |
| region from NCCT. |
| ASPECTS score. |
| Colour coded |
| overlay |
| of regions of blood |
| vessel density |
| asymmetry from |
| CTA. Identification |
| of LVO in the ICA |
| or MCA. Hypo- |
| attenuation and |
| mismatch volume |
| from CTP. |
|
|
FDA (II), CE (I) |
| SHUKUN |
|
|
|
| Segments ICH and |
| ischaemia from |
| NCCT. Provides |
| diameter measure- |
| ments and |
| ASPECTS. |
| Measures |
| dimensions of |
| BA from CTA. |
|
AI |
CE (I) |
| Viz.ai |
|
|
|
| Detection of LVO |
| and BA from CTA. |
| Detection of ICH |
| and SDH from |
| NCCT. |
|
DL |
| FDA (II), CE (I) |
| (Viz LVO) |
| (Viz ICH) |
| FDA (II) |
| (Viz |
| ANEURYSM) |
|
| VUNO |
DeepBrain |
|
|
| Brain atrophy per |
| region, WMH, and |
| cortical thickness. |
| Brain structures |
| segmented include |
| 2 vessels. |
|
DL |
FDA (II), CE (IIa) |
| Heuron |
| StroCare |
| Suite, |
| AgingCare |
| Suite |
|
|
|
| ICH detection and |
| triage from NCCT. |
| LVO detection and |
| hemisphere from |
| NCCT. ASPECTS |
| and regional analy- |
| sis from NCCT. |
| LVO detection and |
| hemisphere from |
| CTA. Volume mis- |
| match from CTP. |
| Atrophy per region |
| from T1. |
|
AI |
| FDA (II) |
| (StroCare Suite |
| ICH) |
|
| Quibim |
QP-Brain |
|
|
| Brain atrophy per |
| region from T1. |
| Segmentation and |
| volume of WMH |
| and longitudinal |
| analysis from |
| FLAIR. |
|
AI, DL |
FDA (II), CE (IIb) |
| QYNAPSE |
QyScore |
|
|
| Brain atrophy per |
| region from T1. |
| Segmentation and |
| volume of WMH |
| from T1 and FLAIR. |
|
AI |
FDA (II), CE (IIa) |
| United Imaging |
| Intelligence |
|
|
| ICH, ISL, |
| WMH, |
| Atrophy, |
| PVS, |
| Lacunes, |
| CMB, BA |
|
|
| Segmentation of |
| ICH, edema, and |
| midline shift from |
| NCCT. ASPECTS |
| score per region |
| from NCCT. |
| Detection of BA |
| from CTA. Segmen- |
| tation of infarct core |
| and mismatch areas |
| from CTP. Quantit- |
| ative evaluation of |
| ISL, lacunes, WMH, |
| PVS, CMB, and |
| atrophy from MRI to |
| provide a total |
| CSVD score. |
|
AI |
- |